KOTLER KEVIN
Transactions
50
Companies
13
Filings
8
CIK
0001601692
Recent Transactions
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Other
- Conversion
- Conversion
Series B Convertible Preferred Stock
2022-02-11$10000.00/sh−436→ 0 total - Award
- Award
- Exercise/Conversion
- Exercise/Conversion
- Purchase
- Purchase
- Purchase
- Conversion
Stock Options (right to buy)
2021-08-10$2.93/sh+15,000→ 7,500 total - Exercise/Conversion
- Exercise/Conversion
- Exercise/Conversion
- Purchase
- Purchase
- Purchase
- Exercise/Conversion
- Exercise/Conversion
- Exercise/Conversion
- Conversion
- Conversion
- Exercise/Conversion
- Conversion
- Conversion
Series B Convertible Preferred Stock
2019-12-20$10000.00/sh−360→ 436 total - Sale
- Sale
- Sale
- Conversion
Series B Convertible Preferred Stock
2019-11-18$10000.00/sh−720→ 796 total - Sale
- Sale
- Conversion
- Sale
- Exercise/Conversion
- Exercise/Conversion
- Award
- Disposition to Issuer
- Sale
- Conversion
Series B Convertible Preferred Stock
2019-05-10$10000.00/sh+324→ 1,516 total - Sale
- Conversion
Series B Convertible Preferred Stock
2019-04-11$10000.00/sh+360→ 1,840 total - Award
- Sale
Common Shares, without par value
2018-12-27$0.85/sh−56,316→ 1,598,553 total - Sale
Common Shares, without par value
2018-12-27$0.85/sh−100,000→ 1,498,553 total - Sale
Common Shares, without par value
2018-12-27$0.88/sh−14,800→ 1,654,869 total - Sale
Common Shares, without par value
2018-12-26$0.87/sh−109,900→ 1,741,359 total - Sale
Common Shares, without par value
2018-12-26$0.91/sh−12,219→ 1,729,140 total
Companies
13Aegerion Pharmaceuticals, Inc.
10% Owner
ARATANA THERAPEUTICS, INC.
10% Owner
- $AVDL
AVADEL PHARMACEUTICALS PLC
10% Owner
BIODELIVERY SCIENCES INTERNATIONAL INC
Director
Corium International, Inc.
10% Owner
Dex Liquidating Co.
10% Owner, See Explanation of Responses
- $HRTX
HERON THERAPEUTICS, INC. /DE/
Director
Mirati Therapeutics, Inc.
10% Owner
NOVELION THERAPEUTICS INC.
Director, 10% Owner
PROGENICS PHARMACEUTICALS INC
10% Owner
Societal CDMO, Inc.
10% Owner
- $SSKN
STRATA Skin Sciences, Inc.
10% Owner
- $TVTX
Travere Therapeutics, Inc.
10% Owner
Recent Filings
8- 4
Broadfin Healthcare Master Fund Ltd
Mar 22, 2022
- 4
Broadfin Healthcare Master Fund Ltd
Feb 15, 2022
- 4
Broadfin Healthcare Master Fund Ltd
Jan 31, 2022
- 4
Broadfin Healthcare Master Fund Ltd
Nov 22, 2021
- 4
Broadfin Healthcare Master Fund Ltd
Nov 15, 2021
- 4
Broadfin Healthcare Master Fund Ltd
Nov 9, 2021
- 4
Broadfin Healthcare Master Fund Ltd
Aug 10, 2021
- 4
Broadfin Healthcare Master Fund Ltd
May 13, 2021
Address
C/O BROADFIN CAPITAL, LLC 300 PARK AVENUE, 25TH FLOOR
NEW YORK, NY, 10022